Submitted by Anonymous (not verified) on 31 October 2023 - 15:53
Human medicines European public assessment report (EPAR): Venclyxto, venetoclax, Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 04/12/2016, Revision: 16, Status: Authorised
Source: